Selskabets formål er at drive virksomhed indenfor bioteknologi og anden dermed i forbindelse stående virksomhed.
| Year | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2024 | 111.2 mio. | 52.6 mio. | 307 mio. | 176.9 mio. | 31 | |
CVR: 30582462
Secondary names: NORDIC BIOSCIENCE CLINICAL DEVELOPMENT A/S
Previous names: NORDIC BIOSCIENCE PROJECT 2 A/S, NORDIC BIOSCIENCE CLINICAL DEVELOPMENT A/S
1 properties
Upgrade to Pro to see addresses, building data and ownership details
Compared to 997 companies in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Comparison is based on industry median values
Mark Høgh Gandrup joined as director
Jakob Brix Christensen left as director
Companies in the same industry and area
CVR 45576310
CVR 37918806
CVR 34173427
CVR 45943062
CVR 41093447
companydata.dk